In a bold move that defies the current trend of dwindling medical research funds, the Canterbury Medical Research Foundation (CMRF) has stepped up with a groundbreaking $1.5 million investment—its largest ever. But here’s where it gets even more impactful: this funding isn’t just a number; it’s a lifeline for 11 critical research projects tackling some of the most pressing health challenges of our time. From pancreatic, blood, and breast cancers to heart disease, mental health, Parkinson’s, and child health, this investment is set to transform lives—not just in Canterbury, but across New Zealand and beyond.
And this is the part most people miss: while government and private funding for medical research in New Zealand is at an all-time low, CMRF’s commitment stands as a beacon of hope. Sue Sullivan, CMRF Chair, reflects on this milestone: ‘We’re humbled by the generosity of our supporters and inspired by the researchers who are making a tangible difference, both locally and globally.’ This year’s funding isn’t just about money; it’s about empowering world-class research that addresses significant health issues head-on.
CMRF Chief Executive Melissa Haberfield highlights the foundation’s role in fostering innovation: ‘We’re thrilled to support both emerging talent and seasoned researchers, thanks to the incredible bequests and donations from our community.’ With 38 active research projects and over $36 million invested to date, CMRF is the South Island’s largest independent funder of medical research—and at 65 years old, it shows no signs of slowing down. ‘Our supporters’ commitment ensures we can continue to make a real impact on the wellbeing of our region,’ Sullivan adds.
This year’s grants are a testament to CMRF’s reach and ambition. Eight Major Project Grants totaling $960,000, two Emerging Researcher Fellowships valued at $435,000, and a Special Project Grant of $85,000 were awarded, alongside smaller grants like travel funds and a PhD scholarship. Notably, the University of Otago, Christchurch, secured eight of the 11 grants, fueling groundbreaking work such as using vitamin C to manage leukemia, advancing pancreatic cancer treatments, and identifying genetic risks for heart disease.
Here’s where it gets controversial: while these projects are undeniably vital, the question remains—are we doing enough to sustain long-term research funding? Professor Lutz Beckert, Dean of the University of Otago Faculty of Medicine in Christchurch, praises CMRF’s support but underscores the need for continued investment: ‘This funding is crucial, but we must ensure our researchers have the resources to tackle these challenges over the long haul.’
Among the standout recipients is Dr. Michael Newton-Vesty from the University of Canterbury, who received a Major Project Grant for his work on viral enzyme treatments to combat antibiotic-resistant bacteria—a global health crisis. Meanwhile, emerging researchers like Dr. George Wiggins (University of Otago Christchurch) and Dr. Ella Guy (University of Canterbury) are pioneering new approaches to cancer prevention and low-cost respiratory disease treatments, respectively.
But here’s the bigger question: as we celebrate these advancements, how can we ensure that medical research remains a priority in an era of shrinking budgets? Haberfield emphasizes the urgency: ‘Now more than ever, we need to back our brightest minds in health research.’ The grants will be officially awarded at a special cocktail function later this month, marking CMRF’s 65th anniversary—a fitting celebration of its enduring impact.
What do you think? Is enough being done to support medical research, or are we falling short? Share your thoughts in the comments—let’s spark a conversation that could shape the future of healthcare.
